Showing 36,902 results

New & experimental hepatitis C treatment

HCV polymerase inhibitor mericitabine boosts interferon/ribavirin cure rate

Editor's pick
HIVandHepatitis.com
13 February 2013
Pharmaceutical industry

EMA: Viracept: Non-renewal of the marketing authorisation in the European Union

Editor's pick
European Medicines Agency
7 February 2013
Access to healthcare

UCAB: Medicines will disappear from pharmacies in Ukraine starting from the 1st of March

Editor's pick
EATG
7 February 2013
New & experimental HIV treatments

ViiV announces halt to lersivirine development

Editor's pick
HIVandHepatitis.com
7 February 2013
Migrants, refugees & displaced people

ECDC meeting report: Responses to HIV and migration in western industrialised countries: current challenges, promising practices, future directions

Editor's pick
ECDC press release
1 February 2013
Drug-resistant TB

Cochrane review gives thumbs up to GeneXpert test for detection of MDR-TB

Editor's pick
Citizen News Service
1 February 2013
Pharmaceutical industry

US finds sharp rise in ‘pay-for-delay’ deals blocking generics

Editor's pick
Intellectual Property Watch
21 January 2013
Child developmental issues

Bone mineral density below normal in children infected early with HIV

Editor's pick
International AIDS Society
21 January 2013
Hepatitis C symptoms & diagnosis

Rapid pace of liver damage in recent HCV co-infection

Editor's pick
CATIE
21 January 2013
Drug-resistant TB

CDC report on U.S. TB drug shortage reflects local and global challenges

Editor's pick
Science Speaks
21 January 2013
Pharmaceutical industry

Médecins Sans Frontières addresses study by Massachusetts General Hospital on implications of switching from branded to generic antiretrovirals for HIV

Editor's pick
MSF / EATG
17 January 2013
Bone & joint problems

HIV treatment interruption associated with reduced bone loss in SMART trial

Editor's pick
HIVandHepatitis.com
16 January 2013
HIV treatment

Top 12 HIV and Hepatitis Stories of 2012

Editor's pick
HIVandHepatitis.com
3 January 2013
New & experimental HIV treatments

ViiV Healthcare announces regulatory submissions for dolutegravir in the EU, US and Canada

Editor's pick
ViiV press release
18 December 2012
Hepatitis C transmission & prevention

HIV+ MSM have 4 times HCV risk of HIV-negative MSM in meta-analysis

Editor's pick
International AIDS Society
17 December 2012
Government, leadership & policy

EU trio presidency programme 1 January 2013- 30 June 2014 and public health

Editor's pick
EATG
17 December 2012
Discrimination & the law

The Eurasian Coalition on Male Health urges the governments of Eastern Europe and Central Asia to stop the adoption of laws prohibiting `homosexual propaganda`

Editor's pick
EATG
12 December 2012
Access to healthcare

Brazil enters new era of co-production of anti-AIDS drugs

Editor's pick
Inter Press Service
10 December 2012
Access to healthcare

Advocates to drugmakers: Join Patent Pool or else

Editor's pick
Pharmalot
6 December 2012
TB diagnosis

United States government announces $11 million in additional support for rapid TB test in 14 countries

Editor's pick
PEPFAR press release
6 December 2012
Pharmaceutical industry

ITPC Open letter from activists in EECA about the Galien Prix Award goint to Merck for boceprevir

Editor's pick
EATG
6 December 2012
Side effects

Liver toxicity uncommon with modern antiretroviral drugs, but higher risk for HIV/HCV coinfected

Editor's pick
HIVandHepatitis.com
6 December 2012
Access to healthcare

UNITAID statement on Johnson & Johnson’s darunavir announcement

Editor's pick
UNITAID press release
5 December 2012
Harm reduction

New EMCDDA report shows heroin use in decline and patterns of drug use shifting

Editor's pick
European Monitoring Centre for Drugs and Drug Addiction
5 December 2012